Context Therapeutics Inc. (CNTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.79
Day's range
$3.16

Context Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BIOIMPACT CAPITAL LLC 05/15/2026 10.68 M $27.98 M   0.00% 11.62%
NEXTECH INVEST, LTD. 05/15/2026 7.42 M $19.44 M   0.00% 8.08%
DEEP TRACK CAPITAL, LP 05/15/2026 7.42 M $19.44 M   0.00% 8.08%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 6.96 M $18.24 M   100.00% 7.58%
OCTAGON CAPITAL ADVISORS LP 05/15/2026 5.25 M $13.76 M   100.00% 5.71%
BLUE OWL CAPITAL HOLDINGS LP 05/14/2026 5.09 M $13.33 M   -31.53% 5.54%
AVIDITY PARTNERS MANAGEMENT LP 05/28/2026 5.00 M $13.10 M   -9.20% 5.44%
FRANKLIN RESOURCES INC 05/13/2026 3.80 M $9.96 M   -5.00% 4.14%
05/15/2026 3.43 M $8.99 M   100.00% 3.74%
MARSHALL WACE, LLP 05/15/2026 2.95 M $7.72 M   13.70% 3.21%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 2.68 M $7.03 M   100.00% 2.92%
GREAT POINT PARTNERS LLC 05/15/2026 2.24 M $5.86 M   -52.21% 2.44%
MILLENNIUM MANAGEMENT LLC 05/15/2026 1.42 M $3.73 M   -45.24% 1.55%
05/15/2026 1.10 M $2.88 M   100.00% 1.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 1.09 M $2.87 M   100.00% 1.19%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 1.00 M $2.62 M   100.00% 1.09%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 917.92 K $2.40 M   -31.58% 1.00%
BLACKROCK, INC. 05/13/2026 846.70 K $2.22 M   -0.16% 0.92%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 603.77 K $1.58 M   -0.77% 0.66%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 529.55 K $1.39 M   100.00% 0.58%
JANE STREET GROUP, LLC 05/12/2026 436.93 K $1.14 M   100.00% 0.48%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 351.09 K $919.87 K   0.00% 0.38%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 341.34 K $894.32 K   100.00% 0.37%
GOLDMAN SACHS GROUP INC 05/15/2026 287.30 K $752.72 K   100.00% 0.31%
WOODLINE PARTNERS LP 05/15/2026 250.09 K $655.23 K   100.00% 0.27%
STATE STREET CORP 05/15/2026 233.51 K $611.79 K   41.00% 0.25%
06/04/2026 190.79 K $499.86 K   100.00% 0.21%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 183.00 K $479.46 K   -64.00% 0.20%
CITADEL ADVISORS LLC 05/15/2026 140.02 K $366.85 K   307.26% 0.15%
HIGHTOWER ADVISORS, LLC 05/05/2026 126.15 K $330.52 K   0.24% 0.14%
BANK OF AMERICA CORP /DE/ 05/18/2026 114.89 K $301.01 K   12,213.83% 0.13%
PATHSTONE HOLDINGS, LLC 05/11/2026 110.24 K $288.84 K   0.00% 0.12%
HRT FINANCIAL LP 05/14/2026 104.97 K $275.00 K   100.00% 0.11%
MILL CREEK CAPITAL ADVISORS, LLC 05/14/2026 104.63 K $274.13 K   0.00% 0.11%
NORTHERN TRUST CORP 05/14/2026 103.26 K $270.53 K   22.51% 0.11%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 05/15/2026 100.00 K $262.00 K   0.00% 0.11%
CLEAR HARBOR ASSET MANAGEMENT, LLC 05/05/2026 92.80 K $243.15 K   0.00% 0.10%
WINTON GROUP LTD 05/12/2026 81.30 K $213.01 K   100.00% 0.09%
OMERS ADMINISTRATION CORP 05/15/2026 80.60 K $211.17 K   100.00% 0.09%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 57.23 K $149.95 K   8.60% 0.06%
AMERICAN CENTURY COMPANIES INC 05/15/2026 50.91 K $133.39 K   100.00% 0.06%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 41.10 K $107.68 K   100.00% 0.04%
CI PRIVATE WEALTH, LLC 05/15/2026 26.53 K $69.52 K   75.91% 0.03%
VIRTU FINANCIAL LLC 05/14/2026 23.10 K $61.00 K   -20.13% 0.03%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 20.22 K $52.98 K   100.00% 0.02%
CERITY PARTNERS LLC 05/15/2026 20.00 K $52.40 K   0.00% 0.02%
SANCTUARY ADVISORS, LLC 05/05/2026 19.32 K $50.61 K   100.00% 0.02%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 12.61 K $33.04 K   100.00% 0.01%
TWO SIGMA SECURITIES, LLC 05/15/2026 12.57 K $32.94 K   100.00% 0.01%
CITIGROUP INC 05/11/2026 12.18 K $31.92 K   803.71% 0.01%

Context Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 70 institutional investors and hedge funds held shares of Context Therapeutics Inc. The most heavily invested institutionals were:

BioImpact Capital LLC: 10.68 M

Nextech Invest, Ltd.: 7.42 M

Deep Track Capital, LP: 7.42 M

Soleus Capital Management, L.P.: 6.96 M

Octagon Capital Advisors LP: 5.25 M

Blue Owl Capital Holdings LP: 5.09 M

77.93% of Context Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 81.74 M shares in the last 24 months. This purchase volume represents approximately $237.04 M in transactions.